Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Rev Cardiovasc Med ; 25(3): 84, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-39076960

RESUMEN

Background: Both systemic-to-pulmonary shunt and right ventricle-pulmonary artery (RV-PA) connection are extensively applied to initially rehabilitate the pulmonary artery in pulmonary atresia with the ventricle septal defect (PA/VSD). However, which of these options is the most ideal for promoting pulmonary artery development and improving outcomes remains controversial. Methods: A total of 109 PA/VSD patients undergoing initial rehabilitative surgery at Guangdong Provincial People's Hospital from 2010 to 2020 were enrolled in this study. A series of clinical data were collected to compare the perioperative and postoperative outcomes between systemic-to-pulmonary and RV-PA connection. Results: The mean duration of follow-up was 61.1 months in the systemic-to-pulmonary shunt group and 70.3 months in the RV-PA connection group (p > 0.05). The RV-PA connection technique resulted in a significantly higher PaO 2 , lower red blood cells (RBC), lower hemoglobin, and lower hematocrit (Hct) (p < 0.05). The cumulative incidence curve estimated a cumulative complete repair rate of 56 ± 7% after 5 years in the RV-PA connection group, significantly higher than 36 ± 7% after 5 years in the systemic-to-pulmonary shunt group (p < 0.05). The Kaplan-Meier curve revealed a similar estimated survival rate between the two groups (p = 0.73). The RV-PA connection was identified as an independent predictor for complete repair in the multivariable analysis (HR = 2.348, 95% CI = 1.131-4.873). Conclusions: The RV-PA connection is a more ideal initial rehabilitative technique than systemic-to-pulmonary shunt in treating PA/VSD as a consequence of comparable probability of survival but improved definitive complete repair rate.

2.
Anal Chem ; 91(9): 5753-5761, 2019 05 07.
Artículo en Inglés | MEDLINE | ID: mdl-30968692

RESUMEN

The construction of efficient nanozyme with multienzyme activities in a simple way is vital for the wide biological and chemical applications. Generally, the mimic enzyme activities depend on their sizes, surface states, and materials types. Quantum dots (QDs), one type of zero-dimensional nanomaterials, are much appealing due to their abundant catalytically active surface deficiency. The vanadium oxide (VO x) is one special transition metal oxides possessing different valence states. Inspired by these views, we synthesized VO xQDs herein via a one-pot top-down ethanol-thermal method using bulk VO2 as the precursor. The VO xQDs showed not only oxidase- and peroxidase-like activities in ethanol as the main background solution (ethanol-BGS), but also exhibited additional superoxide dismutase mimetic activity in phosphate buffer solution. Furthermore, the TMB-VO xQDs system in the ethanol-BGS produced three distinct colors in the presence of hydrogen peroxide (H2O2) at three different concentration gradients (10-90 µM, 0.1-10 mM, and 20-100 mM). Accordingly, we constructed a three-dimensional (3D) coordinate system (3D-CS) by using the three variables: the initial velocities, the maximum absorption values and the visual colors of the enzymatic reaction system. As a result, the rapid detection of H2O2 can be achieved while effectively avoiding the faked appearance due to the inhibition effects to the enzymatic system at too high H2O2 concentration. The applicability of the VO xQDs based 3D-CS was further proved via the facile and accurate H2O2 assays in three different practical samples.


Asunto(s)
Peróxido de Hidrógeno/análisis , Oxidorreductasas/metabolismo , Peroxidasa/metabolismo , Puntos Cuánticos , Superóxido Dismutasa/metabolismo , Compuestos de Vanadio/química , Contaminantes Químicos del Agua/análisis , Monitoreo del Ambiente , Oxidorreductasas/química , Peroxidasa/química , Lluvia/química , Ríos/química , Superóxido Dismutasa/química
3.
Front Cardiovasc Med ; 10: 1033489, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36818352

RESUMEN

Background: Late severe tricuspid regurgitation (TR) after left-side valve surgery (LSVS) is not uncommon. However, the tricuspid valve has been deemed the forgotten valve because the isolated TR is well tolerated with medication, and reoperation has a higher rate of adverse events. With the advancement of minimally invasive techniques, isolated tricuspid valve reoperation (ITVR) via totally endoscopy or transcatheter approach brings the tricuspid valve into spotlight. Our aim is to report the safety and efficacy of minimally invasive ITVR using endoscopic and transcatheter approaches. Methods: From October 2020 to October 2021, 21 patients with LSVS history and secondary massive TR underwent minimally invasive ITVR in our institution. Baseline characteristics, surgical outcomes and follow-up results were analyzed, and data between the totally endoscopy approach and the transcatheter approach were compared. Results: Of the 21 cases, totally endoscopic isolated tricuspid valve surgery (EITVS) accounts for 16 (76.2%) cases, with 14 tricuspid valvuloplasty cases, and 2 tricuspid valve replacement cases; the remaining 5 (23.8%) cases underwent transcatheter tricuspid valve replacement (TTVR). The mean age was (60.0 ± 8.4) years, with 15 (71.4%) being female. Minimally invasive ITVR procedures were 100% successfully performed in all patients without any perioperative mortality, sternotomy conversion, or reoperation. During the median follow-up of 16.8 months (IQR, 13.0-20.6 months), New York Heart Association Class improved significantly from baseline (P = 0.004). TR severity was significantly improved during postoperative and follow-up period (both P < 0.001). Compared with the EITVS group, the TTVR group had a higher clinical risk score [8.00 (8.00, 9.00) vs. 5.00 (3.25, 5.00), P = 0.001], but a higher success rate in reducing TR to less than grade 1+ (100 vs. 43.8%, P = 0.045) at follow-up. Conclusion: In our series, minimally invasive ITVR, including EITVS and TTVR, is a safe and feasible option for severe TR after LSVS, and presents excellent early outcomes in selected patients. TTVR is a reliable alternative for patients with high surgical risk. To improve the results of ITVR, it is necessary to improve patient's preoperative status or perform reoperation before the onset of significant right heart failure. Further studies with a larger sample size and a longer follow-up period are awaited.

4.
Front Cardiovasc Med ; 9: 1023501, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36337888

RESUMEN

The sinus of Valsalva aneurysm (SVA) is a rare cardiac anomaly. It can develop into the heart failure if it ruptures, which requires early intervention. However, such congenital anomalies are usually treated using a median sternotomy approach. Here, we report a rare case of SVA combined with a ventricular septal defect in which the patient underwent patch repair of the defects under a total thoracoscopy approach. She was discharged uneventfully and showed no residual shunt or aortic regurgitation postoperatively or at the 12-month follow-up. The total thoracoscopic approach for SVA repair is technically feasible.

5.
Front Cardiovasc Med ; 9: 1096973, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36741840

RESUMEN

Persistent left superior vena cava (PLSVC) is a relatively rare congenital anomaly in the general population. It plays an important role in initiating and maintaining atrial fibrillation (AF) in some patients. Radiofrequency catheter ablation is the major treatment for patients with AF and PLSVC in most publications. Here, we reported a case of thoracoscopic ablation for a patient with atrial fibrillation and persistent left superior vena cava. After preprocedural simulation using virtual reality, we successfully completed box-lesion, ablation line from superior vena cava to inferior vena cava, left atrial appendage (LAA) excision, and PLSVC ablation. It provides a new perspective on surgical treatment for patients with AF and PLSVC.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA